Study for Panel for the Future of Science and Technology (STOA), European Parliament
European pharmaceutical research and development: Could public infrastructure overcome market failures?
“With a focus on research and development in the area of innovative medicines, this study discusses a new European approach to pharmaceutical policy. After examining the European pharmaceutical sector’s features, and the strengths and weaknesses of the current research and business model, the study explores the need for and the concept of a European infrastructure with a long-term transboundary mission”
Click here to know more